Circulating Antibodies to DNA-RelÁted Antigens in Patients with Autoimmune Thyroid Disorders
Authors:
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 14 (1) , 33-36
Abstract
A high prevalence of antibodies to double-stranded DNA (AbDNAds) has been recently reported in serum of patients with autoimmune thyroid disorders, but the specificity of this finding has been questioned. For this reason, the prevalence of several antibodies to DNA-related nuclear antigens (AbDRENA) has been evaluated in sera of patients with autoimmune and non-autoimmune thyroid disease. The study group included: 46 Graves’ disease patients, 28 Hashimoto's thyroiditis patients, 25 patients with toxic nodular goitre and 11 with non-toxic nodular goitre. Twenty-eight Graves' patients were retested during methimazole (MMI) therapy, and 5 after radioiodine administration. Twenty-two patients with systemic lupus erythematosus and 28 normal subjects served as positive and negative controls, respectively. AbDRENA included: AbDNAds by RIA or immunofluorescence (IF); antibodies to single-stranded DNA (AbDNAss) and antibodies to histone (AbHist) by ELISA methods; antibodies to nuclear antigens (ANA) by immunofluorescence. RIA values were considered to be abnormal when 2 SD above the mean of normal controls. In our study 13% of Graves' patients were positive for AbDNAds by RIA: all of them had negative tests by IF; 11% were positive for AbDNAss. 2% for AbHist and 7% for ANA. A comparable prevalence of positive results for AbDNAds by RIA. with negative IF tests, was found in Hashimoto's thyroiditis patients. No significant changes of antibody levels were observed in Graves' patients during MMI treatment or after radioiodine administration. A positivity for AbDNAds or AbDNAss was found in 8% of patients with toxic nodular goitre, but in none of those with non-toxic goitre. All patients with systemic lupus erythematosus had positive tests for AbDNAds by both RIA and IF. In conclusion, the results of the present study indicate that: (i) the prevalence of anti-DNA antibodies is low and does not differ in the different groups of thyroid patients, irrespective of the presence of thyroid auto-immunity and/or thyroid hyperfunction; and (ii) different techniques (e.g. RIA vs. IF) may provide discrepant results, thus at least partially explaining differences among various series.Keywords
This publication has 10 references indexed in Scilit:
- Antideoxyribonucleic Acid Antibodies in Graves’ Disease*The Journal of Clinical Endocrinology & Metabolism, 1990
- Increase in Antideoxyribonucleic Acid Antibody Titer in Postpartum Aggravation of Autoimmune Thyroid Disease*The Journal of Clinical Endocrinology & Metabolism, 1988
- Improvement of Immunologic Abnormalities Associated with Hyperthyroidism of Graves' Disease during Methimazole TreatmentHormone and Metabolic Research, 1988
- Antibodies to Nuclear Antigens in Graves' DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1988
- Studies of Thyroid Function and Immune Parameters in Patients with Hyperthyroid Graves' Disease in Remission*The Journal of Clinical Endocrinology & Metabolism, 1988
- Presence of Antideoxyribonucleic Acid Antibody in Patients with Hyperthyroidism of Graves’ Disease*The Journal of Clinical Endocrinology & Metabolism, 1987
- Detection of anti-dsDNA as diagnostic tool.Annals of the Rheumatic Diseases, 1981
- Antibodies against Double‐Stranded DNA in Patients with Connective Tissue DiseasesActa Medica Scandinavica, 1978
- An immunofluorescent method using crithidia luciliae to detect antibodies to double‐stranded DNAArthritis & Rheumatism, 1977
- Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1975